crypto currencies to buy Top Related searches

Huatong Co., Ltd.: The sales revenue of live pigs in November was 410 million yuan. Huatong Co., Ltd. announced that in November 2024, the company sold 201,000 pigs, including 10,600 piglets. The sales revenue of live pigs reached 410 million yuan, an increase of 20.56% from the previous month. The average selling price of commercial pigs was 16.5 yuan/kg, down 4.07% from October. In addition, the number of chickens sold in November was 1,205,900, a decrease of 47.69% from the previous month and a year-on-year increase of 19.79%. Chicken sales revenue was 20,213,700 yuan, an increase of 23.65% from the previous month. Sales data are unaudited for investors' reference.The compound annual growth rate of average daily turnover is 30%. The ETF market in Hong Kong is growing rapidly. The compound annual growth rate of average daily turnover in the past five years is as high as 30%, and the average daily turnover in the first 11 months of this year reached HK$ 18.7 billion. According to HKEx, Hong Kong ETF market will continue to innovate and expand with diversified product selection, market structure optimization and international cooperation.Russian Defense Ministry: Russian air defense forces shot down 13 Ukrainian drones in Kursk, Belgorod, Rostov and Lipetsk last night.

Zheng Meiji: It is planned to acquire 16.61% equity of the holding subsidiary Yaxinke Nanjing at RMB 699 million. Zheng Meiji (601717) announced on the evening of December 13th that the company plans to use its own funds of RMB 699 million (including tax) to acquire 16.61% of Yaxinke Nanjing held by other shareholders of the holding subsidiary Yaxinke Industrial Technology (Nanjing) Co., Ltd. (hereinafter referred to as "Yaxinke Nanjing").Beijing Stock Exchange plans to carry out the fifth network-wide test of trading support platform optimization tomorrow. On December 13th, the office of Beijing Stock Exchange and the office of National Stock Transfer Company issued a notice to carry out the fifth network-wide test of trading support platform optimization on December 14th. The participating institutions are Beijing Stock Exchange, National Stock Transfer Company, China Clearing, Shenzhen Stock Connect, securities companies, fund companies and information providers.China Securities Association: Let the margin financing and securities lending business truly become a powerful tool to serve the people's wealth growth and promote the healthy development of the capital market. On December 6, 2024, China Securities Association held a plenary meeting of the professional committee on margin financing and securities lending business in Chongqing. The meeting emphasized that industry organizations should give full play to the functional role of margin financing and securities lending business, strictly implement relevant regulatory requirements, optimize business processes, improve institutional systems, provide quality services to customers, always bear in mind the people-oriented principle, and put the protection of investors' legitimate rights and interests at the core, so that margin financing and securities lending business can truly become a powerful tool to serve the wealth growth of the people and promote the healthy development of the capital market. The meeting summarized the key work of the Committee in 2024 and discussed the work plan for the next stage. In the next step, the Committee will further play a professional and "handle affairs, discuss and communicate" platform role to jointly promote the high-quality development of margin trading and securities lending business.

The financial technology companies supported by Wal-Mart are valued at $2.5 billion. The traditional banking industry is under threat. Wal-Mart is injecting more funds into its newly-started financial start-ups, obtaining a valuation of $2.5 billion for this company, and indicating its ambition to further set foot in the financial services industry. According to informed sources, the world's largest retailer is jointly leading the financing of more than 300 million US dollars with investment company Ribbit Capital. This marks a new valuation for the company named One, in which Wal-Mart holds a majority stake. Wal-Mart has been providing products to many customers and employees in order to gain a greater foothold in the field of financial services. For the financial industry, the threat of Wal-Mart and other companies encroaching on its territory is getting closer and closer. Just last year, JPMorgan Chase CEO Jamie Dimon mentioned the competitive threat of Wal-Mart and other enterprises, pointing out that its hundreds of millions of customers and huge resources at its disposal were "extraordinary competitive advantages".Zhang Liling, Assistant Managing Director (Economic Research) of the Hong Kong Monetary Authority, will leave in May next year. On December 13th, the Hong Kong Monetary Authority announced that Ms. Zhang Liling, Assistant Managing Director (Economic Research), has resigned for personal reasons and will leave in May 2025. The Hong Kong Monetary Authority will arrange an open recruitment for the post of Assistant President (Economic Research), and will make a separate announcement after the recruitment process is completed.Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.